Group I | Group II | Type-I θI ± s.e. | LRT | Qk> 0.80 | Critical amino acid sites |
---|---|---|---|---|---|
EXPA | EXPB | 0.510± 0.074 | 41.57095 | 6 | 131E,139Q,144I,146P,161R, 164I |
EXPA | EXlA | 1.045± 0.153 | 42.87446 | 46 | 83E,84L,85R,126H,127F,128D,129M,130A,131E,132P,133A,134F,135L,136H,137I,138A,139Q,141R,143G,144I,145V,146P,147V,148S,152F,156K,157K,158G,160I,161R,163T,164I,165N,166G*,168S,169Y*,170F*,171N,182G*,183D,184A,185Q,186S,187V,188S,189I |
EXPB | EXlA | 1.152±0.148 | 45.60237 | 45 | 83E,84L,85R,126H,127F,128D,129M,130A,131E,132P,133A,134F,135L,136H,137I,138A,139Q,141R143G,144I,145V,146P,147V,148S,152F,156K,157K,158G,160I,161R,163T,164I,165N,166G*,168S,169Y*,170F*,171N,182G*,183D,184A,185Q,186S,187V,188S,189I |